These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 10674995)

  • 1. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
    Licastro F; Pedrini S; Caputo L; Annoni G; Davis LJ; Ferri C; Casadei V; Grimaldi LM
    J Neuroimmunol; 2000 Feb; 103(1):97-102. PubMed ID: 10674995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk.
    Licastro F; Pedrini S; Ferri C; Casadei V; Govoni M; Pession A; Sciacca FL; Veglia F; Annoni G; Bonafè M; Olivieri F; Franceschi C; Grimaldi LM
    Ann Neurol; 2000 Sep; 48(3):388-91. PubMed ID: 10976648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response.
    Licastro F; Morini MC; Polazzi E; Davis LJ
    J Neuroimmunol; 1995 Mar; 57(1-2):71-5. PubMed ID: 7535791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin.
    Lanzrein AS; Johnston CM; Perry VH; Jobst KA; King EM; Smith AD
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):215-27. PubMed ID: 9772027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.
    Pirttila T; Mehta PD; Frey H; Wisniewski HM
    Neurobiol Aging; 1994; 15(3):313-7. PubMed ID: 7936055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.
    Licastro F; Masliah E; Pedrini S; Thal LJ
    Dement Geriatr Cogn Disord; 2000; 11(1):25-8. PubMed ID: 10629358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.
    DeKosky ST; Ikonomovic MD; Wang X; Farlow M; Wisniewski S; Lopez OL; Becker JT; Saxton J; Klunk WE; Sweet R; Kaufer DI; Kamboh MI
    Ann Neurol; 2003 Jan; 53(1):81-90. PubMed ID: 12509851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory hypothesis as a link between Alzheimer's disease and diabetes mellitus.
    Bozluolcay M; Andican G; Fırtına S; Erkol G; Konukoglu D
    Geriatr Gerontol Int; 2016 Oct; 16(10):1161-1166. PubMed ID: 26337250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease.
    Sun YX; Minthon L; Wallmark A; Warkentin S; Blennow K; Janciauskiene S
    Dement Geriatr Cogn Disord; 2003; 16(3):136-44. PubMed ID: 12826739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monomeric and polymeric forms of alpha-1 antichymotrypsin in sera from patients with probable late onset Alzheimer's disease.
    Licastro F; Sirri V; Trerè D; Davis LJ
    Dement Geriatr Cogn Disord; 1997; 8(6):337-42. PubMed ID: 9370085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral cytokine release in Alzheimer patients: correlation with disease severity.
    Sala G; Galimberti G; Canevari C; Raggi ME; Isella V; Facheris M; Appollonio I; Ferrarese C
    Neurobiol Aging; 2003 Nov; 24(7):909-14. PubMed ID: 12928049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.
    Parker DC; Mielke MM; Yu Q; Rosenberg PB; Jain A; Lyketsos CG; Fedarko NS; Oh ES
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):149-54. PubMed ID: 22539447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.
    Porcellini E; Davis EJ; Chiappelli M; Ianni E; Di Stefano G; Forti P; Ravaglia G; Licastro F
    Curr Pharm Des; 2008; 14(26):2659-64. PubMed ID: 18991685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic inflammatory markers in age-associated cognitive impairment and Alzheimer's disease].
    Kliushnik TP; Androsova LV; Mikhaylova NM; Kolykhalov IV; Zozulya SA; Dupin AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):74-79. PubMed ID: 28805765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease.
    Savas S; Kabaroglu C; Alpman A; Sarac F; Yalcin MA; Parıldar Z; Ozkinay F; Kumral E; Akcicek F
    Exp Gerontol; 2016 May; 77():1-6. PubMed ID: 26828804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of plasma alpha 1-antichymotrypsin levels in Alzheimer disease patients and controls and their genetic controls.
    Wang X; DeKosky ST; Ikonomovic MD; Kamboh MI
    Neurobiol Aging; 2002; 23(3):377-82. PubMed ID: 11959399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. There is no correlation between peripheral inflammation and cognitive status at diagnosis in Alzheimer's disease.
    Julian A; Dugast E; Ragot S; Krolak-Salmon P; Berrut G; Dantoine T; Hommet C; Hanon O; Page G; Paccalin M
    Aging Clin Exp Res; 2015 Oct; 27(5):589-94. PubMed ID: 25700558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Infections and Cytokine Levels in Patients with Alzheimer's Disease and Mild Cognitive Impairment Compared with Controls.
    Cestari JA; Fabri GM; Kalil J; Nitrini R; Jacob-Filho W; de Siqueira JT; Siqueira SR
    J Alzheimers Dis; 2016 Apr; 52(4):1479-85. PubMed ID: 27104907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer's Disease (AD) individuals.
    Lombardi VR; García M; Rey L; Cacabelos R
    J Neuroimmunol; 1999 Jun; 97(1-2):163-71. PubMed ID: 10408971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.